These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37964487)

  • 1. De novo variants in KCNA3 cause developmental and epileptic encephalopathy.
    Soldovieri MV; Ambrosino P; Mosca I; Servettini I; Pietrunti F; Belperio G; ; Syrbe S; Taglialatela M; Lemke JR
    Ann Neurol; 2024 Feb; 95(2):365-376. PubMed ID: 37964487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants.
    Miceli F; Guerrini R; Nappi M; Soldovieri MV; Cellini E; Gurnett CA; Parmeggiani L; Mei D; Taglialatela M
    Epilepsia; 2022 Jan; 63(1):e7-e14. PubMed ID: 34778950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies.
    Manivannan SN; Roovers J; Smal N; Myers CT; Turkdogan D; Roelens F; Kanca O; Chung HL; Scholz T; Hermann K; Bierhals T; Caglayan HS; Stamberger H; ; Mefford H; de Jonghe P; Yamamoto S; Weckhuysen S; Bellen HJ
    Brain; 2022 Jun; 145(5):1684-1697. PubMed ID: 34788397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel
    Imbrici P; Conte E; Blunck R; Stregapede F; Liantonio A; Tosi M; D'Adamo MC; De Luca A; Brankovic V; Zanni G
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia.
    Dinoi G; Morin M; Conte E; Mor Shaked H; Coppola MA; D'Adamo MC; Elpeleg O; Liantonio A; Hartmann I; De Luca A; Blunck R; Russo A; Imbrici P
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine.
    Ambrosino P; Ragona F; Mosca I; Vannicola C; Canafoglia L; Solazzi R; Rivolta I; Freri E; Granata T; Messina G; Castellotti B; Gellera C; Soldovieri MV; DiFrancesco JC; Taglialatela M
    Epilepsia; 2023 Jul; 64(7):e148-e155. PubMed ID: 37203213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human
    Wei AD; Wakenight P; Zwingman TA; Bard AM; Sahai N; Willemsen MH; Schelhaas HJ; Stegmann APA; Verhoeven JS; de Man SA; Wessels MW; Kleefstra T; Shinde DN; Helbig KL; Basinger A; Wagner VF; Rodriguez-Buritica D; Bryant E; Millichap JJ; Millen KJ; Dobyns WB; Ramirez JM; Kalume FK
    J Neurophysiol; 2022 Jul; 128(1):40-61. PubMed ID: 35583973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking the motion of the K
    Pantazis A; Kaneko M; Angelini M; Steccanella F; Westerlund AM; Lindström SH; Nilsson M; Delemotte L; Saitta SC; Olcese R
    J Physiol; 2020 Nov; 598(22):5245-5269. PubMed ID: 32833227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss-of-function variants in the KCNQ5 gene are implicated in genetic generalized epilepsies.
    Krüger J; Schubert J; Kegele J; Labalme A; Mao M; Heighway J; Seebohm G; Yan P; Koko M; Aslan-Kara K; Caglayan H; Steinhoff BJ; Weber YG; Keo-Kosal P; Berkovic SF; Hildebrand MS; Petrou S; Krause R; May P; Lesca G; Maljevic S; Lerche H
    EBioMedicine; 2022 Oct; 84():104244. PubMed ID: 36088682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
    Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
    Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.
    Bayat A; Iavarone S; Miceli F; Jakobsen AV; Johannesen KM; Nikanorova M; Ploski R; Szymanska K; Flamini R; Cooper EC; Weckhuysen S; Taglialatela M; Møller RS
    Neurotherapeutics; 2024 Jan; 21(1):e00296. PubMed ID: 38241158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies.
    Masnada S; Hedrich UBS; Gardella E; Schubert J; Kaiwar C; Klee EW; Lanpher BC; Gavrilova RH; Synofzik M; Bast T; Gorman K; King MD; Allen NM; Conroy J; Ben Zeev B; Tzadok M; Korff C; Dubois F; Ramsey K; Narayanan V; Serratosa JM; Giraldez BG; Helbig I; Marsh E; O'Brien M; Bergqvist CA; Binelli A; Porter B; Zaeyen E; Horovitz DD; Wolff M; Marjanovic D; Caglayan HS; Arslan M; Pena SDJ; Sisodiya SM; Balestrini S; Syrbe S; Veggiotti P; Lemke JR; Møller RS; Lerche H; Rubboli G
    Brain; 2017 Sep; 140(9):2337-2354. PubMed ID: 29050392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo KCNB1 mutations in epileptic encephalopathy.
    Torkamani A; Bersell K; Jorge BS; Bjork RL; Friedman JR; Bloss CS; Cohen J; Gupta S; Naidu S; Vanoye CG; George AL; Kearney JA
    Ann Neurol; 2014 Oct; 76(4):529-540. PubMed ID: 25164438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel epileptic encephalopathy mutation in KCNB1 disrupts Kv2.1 ion selectivity, expression, and localization.
    Thiffault I; Speca DJ; Austin DC; Cobb MM; Eum KS; Safina NP; Grote L; Farrow EG; Miller N; Soden S; Kingsmore SF; Trimmer JS; Saunders CJ; Sack JT
    J Gen Physiol; 2015 Nov; 146(5):399-410. PubMed ID: 26503721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo KCNA1 variants in the PVP motif cause infantile epileptic encephalopathy and cognitive impairment similar to recurrent KCNA2 variants.
    Rogers A; Golumbek P; Cellini E; Doccini V; Guerrini R; Wallgren-Pettersson C; Thuresson AC; Gurnett CA
    Am J Med Genet A; 2018 Aug; 176(8):1748-1752. PubMed ID: 30055040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCNA1 gain-of-function epileptic encephalopathy treated with 4-aminopyridine.
    Müller P; Takacs DS; Hedrich UBS; Coorg R; Masters L; Glinton KE; Dai H; Cokley JA; Riviello JJ; Lerche H; Cooper EC
    Ann Clin Transl Neurol; 2023 Apr; 10(4):656-663. PubMed ID: 36793218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission.
    Platzer K; Sticht H; Bupp C; Ganapathi M; Pereira EM; Le Guyader G; Bilan F; Henderson LB; Lemke JR; Taschenberger H; Brose N; Abou Jamra R; Wojcik SM
    Ann Neurol; 2022 Dec; 92(6):958-973. PubMed ID: 36073542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain of function due to increased opening probability by two
    Nappi M; Barrese V; Carotenuto L; Lesca G; Labalme A; Ville D; Smol T; Rama M; Dieux-Coeslier A; Rivier-Ringenbach C; Soldovieri MV; Ambrosino P; Mosca I; Pusch M; Miceli F; Taglialatela M
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2116887119. PubMed ID: 35377796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.
    Corbett MA; Bellows ST; Li M; Carroll R; Micallef S; Carvill GL; Myers CT; Howell KB; Maljevic S; Lerche H; Gazina EV; Mefford HC; Bahlo M; Berkovic SF; Petrou S; Scheffer IE; Gecz J
    Neurology; 2016 Nov; 87(19):1975-1984. PubMed ID: 27733563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.
    Olson HE; Jean-Marçais N; Yang E; Heron D; Tatton-Brown K; van der Zwaag PA; Bijlsma EK; Krock BL; Backer E; Kamsteeg EJ; Sinnema M; Reijnders MRF; Bearden D; Begtrup A; Telegrafi A; Lunsing RJ; Burglen L; Lesca G; Cho MT; Smith LA; Sheidley BR; Moufawad El Achkar C; Pearl PL; Poduri A; Skraban CM; Tarpinian J; Nesbitt AI; Fransen van de Putte DE; Ruivenkamp CAL; Rump P; Chatron N; Sabatier I; De Bellescize J; Guibaud L; Sweetser DA; Waxler JL; Wierenga KJ; ; Donadieu J; Narayanan V; Ramsey KM; ; Nava C; Rivière JB; Vitobello A; Tran Mau-Them F; Philippe C; Bruel AL; Duffourd Y; Thomas L; Lelieveld SH; Schuurs-Hoeijmakers J; Brunner HG; Keren B; Thevenon J; Faivre L; Thomas G; Thauvin-Robinet C
    Am J Hum Genet; 2018 May; 102(5):995-1007. PubMed ID: 29656858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.